U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. Gammaplex 5% & 10%
  1. Approved Blood Products

Gammaplex 5% & 10%

STN: BL 125329
Proper Name: Immune Globulin Intravenous (Human) Liquid 
Tradename: Gammaplex 5% & 10%
Manufacturer: Bio Products Laboratory
Indication: 

  • Gammaplex 5%: For the treatment of (1) primary humoral immunodeficiency (PI) in adults and pediatric patients two years of age and older; (2) chronic immune thrombocytopenic purpura (ITP)
  • Gammaplex 10%: For the treatment of (1) primary humoral immunodeficiency (PI) in adults; (2) chronic immune thrombocytopenic purpura (ITP) in adults

Product Information

Supporting Documents

Back to Top